European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
出版年份 2017 全文链接
标题
European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease
作者
关键词
-
出版物
Journal of Crohns & Colitis
Volume 12, Issue 1, Pages 17-31
出版商
Oxford University Press (OUP)
发表日期
2017-08-01
DOI
10.1093/ecco-jcc/jjx101
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease
- (2016) Y. Zhulina et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis
- (2016) N. A. Kennedy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The Risk of Relapse after Anti-TNF Discontinuation in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
- (2016) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study
- (2016) M J Casanova et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective Study
- (2016) Talia Zenlea et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Outcome after a dose “de-intensification” strategy with anti-TNF drugs in patients with Crohn's disease
- (2016) María Chaparro et al. Gastroenterologia y Hepatologia
- Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis
- (2016) Klaus Theede et al. INFLAMMATORY BOWEL DISEASES
- Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial
- (2016) Jost Langhorst et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn’s Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis
- (2016) Julien Kirchgesner et al. PLoS One
- Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission
- (2016) Jae Hyun Kim et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Timing for dose-down of 5-ASA depends on mucosal status with ulcerative colitis
- (2016) Fumiaki Takahashi et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse
- (2016) Asuka Nakarai et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease
- (2015) S. Paul et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy
- (2015) J. P. Gisbert et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis
- (2015) T. Yamamoto et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2015) A. Bourrier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
- (2015) Julián Panés et al. BMC GASTROENTEROLOGY
- Long-Term Outcome of Patients With Crohn’s Disease Who Discontinued Infliximab Therapy Upon Clinical Remission
- (2015) Konstantinos Papamichael et al. Clinical Gastroenterology and Hepatology
- A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis
- (2015) Maria Theresa Arias et al. Clinical Gastroenterology and Hepatology
- Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Patients With Crohn’s Disease
- (2015) David Drobne et al. Clinical Gastroenterology and Hepatology
- A randomized trial comparing 4.8 vs. 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis
- (2015) Roberta Pica et al. DIGESTIVE AND LIVER DISEASE
- Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
- (2015) Niels Vande Casteele et al. GASTROENTEROLOGY
- Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease
- (2015) Joana Torres et al. GASTROENTEROLOGY
- Clinical Practice Guidelines for the Medical Management of Nonhospitalized Ulcerative Colitis: The Toronto Consensus
- (2015) Brian Bressler et al. GASTROENTEROLOGY
- Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety
- (2015) A de Lima et al. GUT
- Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
- (2015) Robert V Bryant et al. GUT
- Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal
- (2015) Estefanía Moreno-Rincón et al. INFLAMMATORY BOWEL DISEASES
- Effectiveness of Adalimumab in Perianal Fistulas in Crohn’s Disease Patients Naive to Anti-TNF Therapy
- (2015) Carlos Castaño-Milla et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Mucosal Healing in Ulcerative Colitis – When Zero is Better
- (2015) Pedro Boal Carvalho et al. Journal of Crohns & Colitis
- Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry
- (2015) Jordi Gordillo et al. Journal of Crohns & Colitis
- Efficacy of Sustained Combination Therapy for at Least 6 Months with Thiopurines and Infliximab in Patients with Ulcerative Colitis in Clinical Remission: A Retrospective Multicenter French Experience
- (2015) J. Filippi et al. Journal of Crohns & Colitis
- Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study
- (2015) Manuel Barreiro-de Acosta et al. Journal of Crohns & Colitis
- Monotherapy With Infliximab Versus Combination Therapy in the Maintenance of Clinical Remission in Children With Moderate to Severe Crohn Disease
- (2015) Jarosław Kierkuś et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
- (2015) Martin Bortlik et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Are faecal markers good indicators of mucosal healing in inflammatory bowel disease?
- (2015) Gudula JAM Boon WORLD JOURNAL OF GASTROENTEROLOGY
- Disease monitoring in inflammatory bowel disease
- (2015) Shannon Chang WORLD JOURNAL OF GASTROENTEROLOGY
- The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease
- (2014) A. M. Schoepfer et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases
- (2014) B. Pariente et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients
- (2014) N. A. Kennedy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Mesalamine Dose Escalation Reduces Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
- (2014) Mark T. Osterman et al. Clinical Gastroenterology and Hepatology
- Thiopurines and Risk of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease: A Meta-analysis
- (2014) Tine Jess et al. Clinical Gastroenterology and Hepatology
- Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease
- (2014) Anthony Lopez et al. Clinical Gastroenterology and Hepatology
- Postoperative Therapy With Infliximab Prevents Long-term Crohn’s Disease Recurrence
- (2014) Miguel Regueiro et al. Clinical Gastroenterology and Hepatology
- Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy
- (2014) Filip Baert et al. Clinical Gastroenterology and Hepatology
- Assessment of the Influence of Inflammation and FCGR3A Genotype on Infliximab Pharmacokinetics and Time to Relapse in Patients with Crohn’s Disease
- (2014) David Ternant et al. CLINICAL PHARMACOKINETICS
- Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study
- (2014) Armelle Chauvin et al. DIGESTIVE AND LIVER DISEASE
- Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease
- (2014) Heimo H. Wenzl et al. DIGESTIVE DISEASES AND SCIENCES
- How safe is infliximab therapy during pregnancy and lactation in inflammatory bowel disease?
- (2014) María Chaparro et al. Expert Opinion On Drug Safety
- Sa1270 Can We Increase the Dose Interval of Infliximab to 10 Weeks Without Risking Loss of Response in Patients With Crohn's Disease? Prospective, Single-Center Pilot Study Based on Successive Measurements of Fecal Calprotectin
- (2014) Gerassimos J. Mantzaris et al. GASTROENTEROLOGY
- Clinical Utility of Fecal Biomarkers for the Diagnosis and Management of Inflammatory Bowel Disease
- (2014) Uri Kopylov et al. INFLAMMATORY BOWEL DISEASES
- Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission
- (2014) Dario Sorrentino et al. INFLAMMATORY BOWEL DISEASES
- 5-Aminosalicylates Reduce the Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis: An Updated Meta-Analysis
- (2014) Li-Na Zhao et al. PLoS One
- Mucosal Healing Did Not Predict Sustained Clinical Remission in Patients with IBD after Discontinuation of One-Year Infliximab Therapy
- (2014) Cong Dai et al. PLoS One
- Frequency and prognostic role of mucosal healing in patients with Crohn’s disease and ulcerative colitis after one-year of biological therapy
- (2014) Klaudia Farkas WORLD JOURNAL OF GASTROENTEROLOGY
- Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study
- (2014) Anders Lasson et al. United European Gastroenterology Journal
- Safety of Anti-TNF Agents During Pregnancy and Breastfeeding in Women With Inflammatory Bowel Disease
- (2013) Javier P Gisbert et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials
- (2013) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pouchitis: What Every Gastroenterologist Needs to Know
- (2013) Bo Shen Clinical Gastroenterology and Hepatology
- Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
- (2013) Remo Panaccione et al. GASTROENTEROLOGY
- Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
- (2013) Martine De Vos et al. INFLAMMATORY BOWEL DISEASES
- Long-Term Mesalamine Maintenance in Ulcerative Colitis
- (2013) Nabeel Khan et al. INFLAMMATORY BOWEL DISEASES
- Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe
- (2013) Johan Burisch et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy
- (2013) Takayuki Yamamoto et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis
- (2013) Nikos Viazis et al. Journal of Crohns & Colitis
- Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
- (2013) Fernando Magro et al. Journal of Crohns & Colitis
- Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy
- (2013) Klaudia Farkas et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn's disease
- (2013) Renathe Rismo et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
- (2012) T. Molnár et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Perception gaps between patients with ulcerative colitis and healthcare professionals: an online survey
- (2012) Stefan Schreiber et al. BMC GASTROENTEROLOGY
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
- (2012) Maria Chaparro et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies
- (2012) Ren Mao et al. INFLAMMATORY BOWEL DISEASES
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease
- (2012) Geert DʼHaens et al. INFLAMMATORY BOWEL DISEASES
- “One more time” 5-ASA retrial after a glucocorticosteroid induced remission in moderate to severe ulcerative colitis: A prospective community practice experience
- (2012) Seth Lipka et al. Journal of Crohns & Colitis
- Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
- (2012) Filip Baert et al. Journal of Crohns & Colitis
- Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
- (2012) Casper Steenholdt et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Crohn’s disease genotypes of patients in remissionvsrelapses after infliximab discontinuation
- (2012) Cathy Lu WORLD JOURNAL OF GASTROENTEROLOGY
- Evaluation of a daily practice composite score for the assessment of Crohn’s disease: the treatment impact of certolizumab pegol
- (2011) B. G. Feagan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis
- (2011) Alexander C Ford et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis
- (2011) Alexander C. Ford et al. Clinical Gastroenterology and Hepatology
- Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn’s Disease: A Meta-Analysis
- (2011) Helen French et al. DIGESTIVE DISEASES AND SCIENCES
- Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
- (2011) Laurent Peyrin–Biroulet et al. GASTROENTEROLOGY
- Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
- (2011) Edouard Louis et al. GASTROENTEROLOGY
- Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission
- (2011) Kofi Clarke et al. INFLAMMATORY BOWEL DISEASES
- Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids
- (2011) C. Bello et al. Journal of Crohns & Colitis
- Results from the 2nd Scientific Workshop of the ECCO (I): Impact of mucosal healing on the course of inflammatory bowel disease
- (2011) Laurent Peyrin-Biroulet et al. Journal of Crohns & Colitis
- Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease - modelling outcomes in active luminal and fistulizing disease in adults
- (2010) J. LINDSAY et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
- (2010) A. W. G. Waugh et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
- (2010) Abderrahim Oussalah et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
- (2010) Y. Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Low-Dose Maintenance Therapy With Infliximab Prevents Postsurgical Recurrence of Crohn's Disease
- (2010) Dario Sorrentino et al. Clinical Gastroenterology and Hepatology
- Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging
- (2010) Konstantinos Karmiris et al. Clinical Gastroenterology and Hepatology
- 5-Aminosalicylic acid dependency in Crohn's disease: A Danish Crohn Colitis Database study
- (2010) Dana Duricova et al. Journal of Crohns & Colitis
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
- (2009) Andrea Cassinotti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
- (2009) Filip Baert et al. GASTROENTEROLOGY
- Management and prevention of postoperative Crohnʼs disease
- (2009) Miguel Regueiro INFLAMMATORY BOWEL DISEASES
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Current Smoking, Not Duration of Remission, Delays Crohnʼs Disease Relapse Following Azathioprine Withdrawal
- (2009) Harry Sokol et al. INFLAMMATORY BOWEL DISEASES
- Effect of discontinuing TNFα antagonist therapy in patients with remission of rheumatoid arthritis
- (2009) Olivier Brocq et al. JOINT BONE SPINE
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review
- (2009) P. Dillon et al. MEDICAL ONCOLOGY
- Clinical implications of mucosal healing for the management of IBD
- (2009) Guillaume Pineton de Chambrun et al. Nature Reviews Gastroenterology & Hepatology
- Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
- (2008) P. D. R. HIGGINS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
- (2008) Xavier Treton et al. Clinical Gastroenterology and Hepatology
- Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment
- (2008) G. Bresci et al. Colorectal Disease
- Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease
- (2008) R. Berni Canani et al. DIGESTIVE AND LIVER DISEASE
- Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial
- (2008) Gert Van Assche et al. GASTROENTEROLOGY
- Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection
- (2008) Miguel Regueiro et al. GASTROENTEROLOGY
- Predicting relapse in Crohn's disease: a biopsychosocial model
- (2008) A Bitton et al. GUT
- Is the efficacy of successful infliximab induction therapy maintained for one year lasting without retreatment in different behavior types of Crohn's disease?
- (2008) T. Molnár et al. Journal of Crohns & Colitis
- Combined therapy with infliximab and seton drainage for perianal fistulizing Crohn’s disease with anal endosonographic monitoring: a single-centre experience
- (2008) L. Guidi et al. Techniques in Coloproctology
- C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease
- (2008) Chantal L Koelewijn et al. WORLD JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started